NCT00253565 Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00238147 Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer Status COMPLETED Phase PHASE1
NCT00235235 A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer Status TERMINATED Phase N/A
NCT00230399 Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00227747 Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer Status COMPLETED Phase PHASE3
NCT00227656 Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer Status TERMINATED Phase PHASE2
NCT00226980 A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00226941 A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00217711 Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT00216138 Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck Status TERMINATED Phase PHASE2
NCT00216086 Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer Status TERMINATED Phase PHASE2
NCT00216073 Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00216021 Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00215982 Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00215644 Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer Status COMPLETED Phase PHASE2
NCT00215501 Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00209092 Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer Status COMPLETED Phase PHASE2
NCT00207129 Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT00201825 A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients Status COMPLETED Phase PHASE2